Predicting recurrence in patients with sentinel node-negative melanoma: validation of the EORTC nomogram using population-based data.

Mary-Ann El SharouniT AhmedA J WitkampV SigurdssonC H van GilsO E NiewegRichard A Scolyer John F ThompsonP J van DiestSerigne N Lô

Published in: The British journal of surgery (2020)

This population-based validation confirmed the value of the EORTC nomogram in predicting recurrence-free survival in patients with SN-negative melanoma. The EORTC nomogram could be used in clinical practice for personalizing follow-up and selecting high-risk patients for trials of adjuvant systemic therapy.

Keyphrases